Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Argye Elizabeth Hillis MD, MA Associate Editor

Marinos C. Dalakas MD, FAAN Advisory Board

Mark Hallett MD Editor-in-Chief

See All Experts

Published in Neurology and

Journal Scan / Research · November 19, 2022

Association of Obesity With Disease Outcomes in Patients With MS

Journal of Neurology, Neurosurgery, and Psychiatry

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Not a member?

Join for free

Disclosure statements are available on the authors' profiles:

Michael Kornberg MD, PhD

Journal of Neurology, Neurosurgery, and Psychiatry

Association of obesity with disease outcome in multiple sclerosis

J. Neurol. Neurosurg. Psychiatr. 2022 Nov 01;[EPub Ahead of Print], I Lutfullin, M Eveslage, S Bittner, G Antony, M Flaskamp, F Luessi, A Salmen, B Gisevius, L Klotz, C Korsukewitz, A Berthele, S Groppa, F Then Bergh, B Wildemann, A Bayas, H Tumani, SG Meuth, C Trebst, UK Zettl, F Paul, C Heesen, T Kuempfel, R Gold, B Hemmer, F Zipp, H Wiendl, JD Lünemann

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Multiple Sclerosis

Association of Obesity With Disease Outcomes in Patients With MS

Additional Info

Association of obesity with disease outcome in multiple sclerosis

Further Reading

Detection of Neurologic Changes in Critically Ill Infants Using Deep Learning on Video Data

Hypoglycemic Events May Trigger Acute Ischemic Stroke Within 30 Days in Individuals With Diabetes

Serum NfL Levels at Diagnosis: A Prognostic Indicator for Accelerated Disease Progression in Parkinson's Disease

Subcortical Shape as a Marker for Clinical Staging in Patients With Parkinson's Disease

Appointment Non-Attendance Is Associated With Disease-Modifying Therapy Persistence the Following Year

Embolization of the Middle Meningeal Artery for Chronic Subdural Hematoma

Transcranial Direct Current Stimulation Improves Tardive Dyskinesia in Long-Term Hospitalized Patients With Chronic Schizophrenia

Circular RNA in Patients With Parkinson's Disease: From Involvement in Pathology to Diagnostic Tools in At-Risk Individuals

Adjunctive Middle Meningeal Artery Embolization for Subdural Hematoma

Neurologic Outcomes in People With MS Treated With Immune Checkpoint Inhibitors for Oncologic Indications

FDA Approves Kebilidi for Aromatic L-Amino Acid Decarboxylase Deficiency

Recently Updated